The importance of genetic testing in the diagnosis and management of peripartum cardiomyopathy: a case study
ESC Heart Failure · 04.07.2026 · 13 (4)
DOI: 10.1093/eschf/xvag090 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 01.04.2026. Verfasst von Zoee U D'Costa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UCLA, Los Angeles, 757 Westwood Plaza, Los Angeles, CA 90095, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, UCLA, Los Angeles, 757 Westwood Plaza, Los Angeles, CA 90095, USA.
- Department of Human Genetics, UCLA, Los Angeles, CA, USA.
- Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
- Department of Medicine, Division of Cardiology, UCLA, Los Angeles, CA, USA.
Zitieren
APA
D'Costa, Z. U., Wong, E. K., Zhang, M., Fishbein, G. A., Wang, J., Kamath, M., & Shahandeh, N. (2026). The importance of genetic testing in the diagnosis and management of peripartum cardiomyopathy: a case study. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag090
Vancouver
D'Costa ZU, Wong EK, Zhang M, Fishbein GA, Wang J, Kamath M, et al. The importance of genetic testing in the diagnosis and management of peripartum cardiomyopathy: a case study. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag090
BibTeX
@article{DCosta2026,
author = {D'Costa, Zoee U and Wong, Eugene K and Zhang, Min and Fishbein, Gregory A and Wang, Jessica and Kamath, Megan and Shahandeh, Negeen},
title = {The importance of genetic testing in the diagnosis and management of peripartum cardiomyopathy: a case study},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/eschf/xvag090}
}
EUVIMED